Revision of Guidelines on the Clinical Evaluation Method of Anti-malignant Tumor Medicine
In 2005, we submitted an opinion paper about revising guidelines on the clinical evaluation method of anti-malignant tumor medicine.
While drafting our paper, we kept in mind the Gefinitive, which was first approved in Japan, and which caused a number of deaths due to side effects. Part of our opinion was introduced in the revised guidelines.
Topics
- YAKUGAI Ombudsperson
- Tie-up Group
No Related Information
